Newsbenzinga
Reported Earlier, Taysha Gene Therapies Announces ~$200M Public Offering Of 32,500,001 Common Stock Shares At $6.00 Per Share And Pre-Funded Warrants
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…